
Prevention and control of noncommunicable diseases in Kazakhstan: the case for investment / Farrington, Jill;Kontsevaya, Anna;Dombrovskiy, Vladislav;Small, Roy;Rinaldi, Chiara;Kulikov, Alexey;Yegeubayeva, Saltanat
Tác giả : Farrington, Jill;Kontsevaya, Anna;Dombrovskiy, Vladislav;Small, Roy;Rinaldi, Chiara;Kulikov, Alexey;Yegeubayeva, Saltanat
Nhà xuất bản : World Health Organization. Regional Office for Europe
Năm xuất bản : 2019
Chủ đề : 1. Chronic Disease -- economics. 2. Delivery of Health Care. 3. Health Systems Plans. 4. Healthcare Financing. 5. Kazakhstan. 6. Noncommunicable Diseases -- prevention and control. 7. Technical documents.
Thông tin chi tiết
Tóm tắt : | Noncommunicable diseases (NCDs) such as cancer, cardiovascular disease, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kazakhstan. This report provides evidence through three analyses that NCDs reduce economic output and discusses potential options in response, outlining details of their relative returns on investment. An economic burden analysis shows that economic losses from NCDs (direct and indirect costs) comprise 2.3 trillion tenge, equivalent to 4.5% of gross domestic product in 2017. An intervention costing analysis provides an estimate of the funding required to implement a set of policy interventions for prevention and clinical interventions. A cost–benefit analysis compares these implementation costs with the estimated health gains and identifies which policy packages would give the greatest returns on investment. For example, the salt policy package achieved a benefit-to-cost ratio of 118.4 over 15 years, a return of more than 118 tenge for every 1 tenge invested. viii, 35 p. |
Thông tin dữ liệu nguồn
Thư viện | Ký hiệu xếp giá | Dữ liệu nguồn |
---|---|---|
![]() |
|
https://iris.who.int/handle/10665/346422 |